評論
打印
In today's podcast, the China branch of British drugmaker GlaxoSmithKline has been fined a record 3 billion yuan by a court in the central province of Hunan.
在今天的播報中，湖南省法院對英國葛蘭素史克中國分公司一案進行了裁決，并處罰金30億元。
The Changsha Intermediate People's Court held a closed-door trial on September 19 on the case involving GlaxoSmithKline China which was accused of offering bribes. Five former GSK senior executives, including British national Mark Reilly, were sentenced to suspended prison terms of two to three years. Reilly, former head of GSK China, will be forced to leave the country. Reilly and the other executives admitted the charges during the investigation, and the court said that led to lighter punishments. The fine is the biggest that a Chinese court has ever handed a company, said Cheng Baoku, a law professor at Nankai University in Tianjin.
9月19日，長沙中級人民法院對英國葛蘭素史克中國分公司涉嫌行賄一案進行了非公開審理。5名前葛蘭素史克公司的高級管理人員，包括英國人馬克銳，他被判處有期徒刑3年，緩刑四年的處罰。賴利，前葛蘭素史克中國分公司總經理被驅逐出境。賴利以及其他幾名管理人員在調查過程中對罪行供認不諱，法院稱他們將受到較輕的處罰。天津南開大學法律教授程寶庫稱這樣巨額的經濟處罰是中國法院所從未遇到過的。
For Caixin Online, this is Diana Bates.
這是戴安娜·貝茨為您帶來的財新報道。
譯文屬可可英語原創，未經允許，不得轉載。
